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1. Introduction
The detection of cardiac arrhythmia and the differential algorithm used for the recognition of
ventricular tachycardia (VT) or ventricular fibrillation (VF) necessitating internal cardiac de‐
fibrillator (ICD) therapy is one of the most critical issues in ICD patients. Main goal is to devel‐
op algorithms with the highest possible sensitivity to avoid untreated arrhythmias and highest
possible specificity to avoid inappropriate ICD therapies. Currently, several device discrimi‐
nation algorithms and their combinations are available. The following chapter tries to explain
the functionality, means, possibilities and restrictions of these ICD discrimination algorithms.
2. Cycle length / heart rate
The cycle length (CL) or heart rate (HR) is a fundament in the detection of tachycardia in
ICD patients. A sustained ventricular HR in adults >250 bpm or a CL <250 ms is very specif‐
ic for fast VT or VF (figure 1 red zone). However, artificial sensing of external impulses
(noise), sensing caused by lead dysfunction (cluster) or inappropriate recognition of signals
(T-wave-oversensing) present diagnostic challenges even in this HR zone. Below this HR al‐
most every type of cardiac arrhythmia should be considered as well for differential diagno‐
sis. The cycle length of both VTs and SVTs are influenced by most antiarrhythmic drugs.
Therefore programming of the ICD should be accordingly adjusted.
3. VT/VF zone
In the last decade of ICD therapy the programming of a single detection zone {eg. SCD-
HeFT[1]} have been replaced by the programming of up to three detection zones with differ‐
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ent discrimination algorithms and therapies (table 1). Moreover, data on the programming
of zones up to 260ms CL with a long detection time are also available {ADVANCE III study
[2]}. Until now, no consensus is accepted concerning the number of detection zones (not at
least in primary prevention indication), nor clear definition of detection windows is given.
Until 2010 most ICDs had no SVT/VT discrimination algorithm available in the VF zone. In
primary prevention a VT zone from 360ms CL with long detection time, SVT/VT discrimina‐
tion up to 260ms CL and anti-tachycardia-pacing (ATP) prior or during charging, along with
a VF zone from 260ms CL without SVT/VT discrimination and maximal energy shock deliv‐
ery was widely recommended. Depending from device a FVT zone was needed to program
an ATP prior or during charging shock up to 280-250ms CL. Newer devices have now inde‐
pendent discrimination algorithm for every detection zone (Medtronic), and provide
SVT/VT discrimination algorithms also in VF zone. Furthermore, ATPprior or during charg‐
ing is available in all zones. In secondary prevention patients with documented VTs, the first
zone should be programmed 10-20ms above (or 10 bpm below) its cycle length. In younger
patients with channel rhythm disorders like long QT syndrome a single zone (<280ms) can
be considered. Patients with secondary prevention, very low ejection fraction or repetitive
syncope need an individualized, more conservative programming with shorter detection in‐
tervals and less ATPs. Different programming examples for tachycardia detection and thera‐
pies in recent studies with primary prevention patients with ICDs of different
manufacturers are listed in table 1.
Figure 1. Notice critical area of VT and VF discrimination in yellow and orange up to 460ms cycle length
Practically, devices in primary prevention patients can be programmed using either single
or two zones with long detection intervals. The programming should be adjusted during the
follow-up in case of arrhythmic events.
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zone VT FVT VF
Study, date and
manufactures 150bpm 200bpm 250bpm
SCD-HeFT[1] 2005
Medtronic
187bpm [18/24 beats) only
Shocks
PAINFREE[13] I 2001
Medtronic
Rx – 188 bpm[12/16]
ATPx2 → Shocks
188 – 250 bpm[12/16 beats)
ATPx2 → Shocks
>250 bpm[12/16 beats)
Shocks only
PAINFREE[14] II 2005
Medtronic
167 – 188 bpm[18/24]
ATPx3 → Shocks
188 – 250 bpm[18/24 beats)
ATPx1 → Shocks vs Shocks
only
>250 bpm[18/24 beats)
Shocks only
EMPIRIC[15] 2006
Medtronic
150 – 200 bpm[16 beats)
ATPx3 → Shocks
200 – 250 bpm[18/24 beats)
ATPx1 → Shocks
>250 bpm[18/24 beats)
Shocks only
PREPARE[16] 2008
Medtronic
167 – 182 bpm
[32 beats)
Monitor
182 – 250 bpm[30/40 beats)
ATPx1 → Shocks
>250 bpm[30/40 beats)
Shocks only
ADVANCE III[2]
Medtronic 2012
187bpm [30/40 beats) ATP
during change
MADIT[17]
1996 Boston
no clear definition no clear definition
MADIT II[6] 2002 Boston 170 – 200 bpm, [1-5 sec
delay) discrimination free,
therapy free or Monitor
>200 bpm[1-3 sec delay)
Shocks
MADIT CRT[18] 2011 Boston
Scientific
170 – 200 bpm
[60s delay), Rhythm ID ATPx1
→ Shocks
200 – 250 bpm
[12 sec delay) Rhythm ID
ATPx1 → Shocks
>250 bpm[2.5 sec delay)
Quick Convert ATP → Shocks
PROVIDE St.Jude Medical
ongoing 2008-"/>
(NCT00743522]
181 – 214 bpm
[25 beats) SVT Discr.
ATPx2 → Shocks
214 – 250 bpm[18 beats)
ATPx1 → Shocks
>250bpm [12 beats)
Shocks only
Table 1. Change in detection for defibrillation therapy over the last ten years in corner stone studies of different
manufactures.
4. Inappropriate ICD therapy
Inappropriate ICD therapy is a delivered ATP and/or shock in absence of VT/VF episode.
Inappropriate ICD therapy has serious consequences: proarrhythmic effect, reduced quality
of life, psychological stress with depression, unnecessary hospitalisation, early battery de‐
pletion duration and even elevated mortality [3]. Up to 80% of inappropriate ICD therapies
are registered in the first year following device implantation [4, 5] figure 2. Atrial fibrillation
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(AF) is the most common cause of inappropriate ICD therapy {MADIT II [6], figure 3}. How‐
ever, concerning the rising number of lead dysfunction resulting in oversensing this can be
changed in the future. In the SCD-HeFT[3] study with single zone of detection and therapy
(18 of 24 beats at a rate ≥188 bpm or ≤320 ms CL) the effect of inappropriate versus appropri‐
ate ICD therapy to the hazard ratio for death (CI 95%) was 1.98 (p=0.002) for inappropriate
therapy only (figure 4).It is unclear whether the inappropriate therapy is a cause or only a
marker of higher mortality. By all means, consensus exists about the importance of avoiding
inappropriate ICD therapies. The incidence of inappropriate ICD therapy depends on the
programming of the device – both detection and therapy, and considerable changes were
observed over the last years (table 2).
Figure 2. Frequency (y line in %) of inappropriate ICD therapies after ICD implantation (x line in month, y line in %)
Nanthakumar K et al[5].
Figure 3. Reasons of inappropriate ICD therapy in MADIT II [4].
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Figure 4. Relation of appropriate and inappropriate ICD therapy in SCD-HeFT to mortality [3].
Year Author Mean age Patients
(n)
% appropriate ICD
therapy
% inappropriate ICD
therapy
1996 Weber et al[19] 462 55 18
2002 Daubert et al[4] 63 719 66 11,5
2003 Nanthakumar et al[5] 60 261 54 44
2004 Rinald et al[20] 60 155 14
2007 Anselmeet al[21] 64 802 28 15
2008 Wilkoff et al[16] 67 700 5,4 (shock, not ATP) 3,6 (shock, not ATP)
Table 2. Incidences of appropriate and inappropriate ICD therapies over the last years. Notice the influence of SVT/VT
discrimination algorithm until CL of 260ms and longer detection intervals.
5. Detection Time (DT) or Number of Interval Detection (NID)
Detection of tachycardia occurs after the registration of a certain amount of heartbeats with‐
in or above the programmed HR zone. Signals with CL according to VF zone have priority
to signals in VT zone(s). Various algorithms are currently used for validation of a tachycar‐
dia: registering of a specified and programmed number of beats - x out of y (Medtronic and
Biotronik, figure 5), a programmed number of beats (x) with resetting after 5 consecutive be‐
low-zonebeats (St. Jude Medical, figure 6) or after a programmed time interval (Boston, fig‐
ure 7). During the last years programming of a long detection time has been established in
primary prophylactic indication (figure 8 and table 1).
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Figure 5. Tachycardia detection of a Medtronic device: TS tachycardia sense in VT1 zone; VS ventricular sense; TF fibril‐
lation sense via VT2 zone; FS fibrillation sense. In this case x=12 (<300ms orange points) out of y=16 signals counted
for detection of a VF episode with spontaneous conversion to sinus rhythm after 22 beats.
Figure 6. Tachycardia detection of a CRT device from St. Jude Medical (dual chamber detection): VS ventricle sense; AS
atrial sense; T tachycardia sense in VT zone; ST tachycardia episode sense; X no correspondence with stored QRS
templet; little minced meat correspondence with stored templet, NID x=12 (orange points) counted to VT episode
with successful ATP. The episode shows a short VA interval with accelerated CL and corresponding templet to intrinsic
activation. That means episode could diagnose as VT with VA conduction and wrong stored templet or as SVT (atrio‐
ventricular node reentry tachycardia) with atypical start.
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Figure 7. Tachcardia detection of a dual chamber device Boston: VS ventricle sense; AS atrial sense (AS) refracted; PVP
atrial refracted after ventricle sense; VT ventricular tachycardia sense; VF ventricular fibrillation in VF zone sense; V-
Epsd ventricular episode ready for duration; V-Dur duration time complete; Stb stability criteria is right; V-Detect ven‐
tricular episodes is detected and therapy ATP begins.
Figure 8. Gunderson at al [23] demonstrate ICD shock therapy which is delivered or aborted in the same VT episode
according to detection interval NID 12 or 18.
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6. Discrimination SVT/VT
Discrimination of SVT and VT may present a challenge not only for devices using artificial
intelligence and programmed algorithms but even for experienced physicians. Principally
the following wide QRS complex arrhythmias should be considered: VT, SVT with bundle
branch block, SVT with accessory pathway or pacing in left (via coronary sinus) or right
ventricle. Table 3 shows the discrimination criteria of the 12 channel ECG for SVT/VT. No
single criterion is sensitive and specific enough to provide sufficient discrimination value.
Therefore, combination of several criteria should be implemented in the device algorithms
to correctly diagnose arrhythmias. Table 4 shows the availability of discrimination criteria in
single or dual chamber ICDs.
ECG criteria sensitivity specificity
QRS width high low
VA dissociation low high
capture beats low high
northwest axis low high
rS missed or long rS in V1 low medium
concordance +/- low high
Brugada criteria LBBB/RBBB[22] medium high
Table 3. Sensitivity (in sense of frequency) and specificity of different ECG criteria for differentiation SVT and VT.
criteria ECG Single chamber Dual chamber
CL or heart rate + + +
stability + + +
Sudden onset + (Holter ECG) + +
morphology + + +
AV rate branch - - +
QRS axis (*Rhythm ID™ Boston) + +(*) +(*)
AVA interval - - +
Sinus Interval History (*St. Jude
Medical) - +(*) -
Capture beats (*PR Logic™Medtronic) + - +(*)
RBBB and LBBB criterias + - -
Table 4. Variation of SVT and VT discrimination criteria in single and dual chamber ICDs (+ achievable; - not achievable).
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7. Stability
Stability is the variability of tachycardia CL (figure 9). In general, VTs have a reasonably stable
CL while numerous SVTs have beat-to-beat variability in their CL (AF, Sinus tachycardia, etc).
However, some SVTs may have stable CL as well: circus movement tachycardia, atrioventricu‐
lar nodal re-entry tachycardia or atrial flutter (Aflut) – so this criterion has his limitations. Even
AF may have a quite stable CL in the case of very high frequency. Anyway, several random‐
ized controlled studies {e.g. MADIT II [7]} proved a significant decrease (p=0.030) of inappro‐
priate ICD therapies (table 5). Therefore, programming of stability criterion is recommended
in single chamber devices up to 260ms CL and indual chamber devices in the case V <A. The
programmed value depends on the manufacturer, and lies in general for single and dual cham‐
ber devices around 40ms (-20 to + 20ms) [8]. Boston and St. Jude Medical use the last 12 consec‐
utive intervals and compare the second longest and the shortest interval to calculate the
difference in ms (or percentage ratio). Medtronic and Biotronik use the last 3 and 4 consecu‐
tive intervals to calculate mean difference.
Figure 9. Notice variability of CL in ms (in red numbers) from beat to beat in normal sinus rhythm, monomorphic ven‐
tricular tachycardia and atrial fibrillation AF.
8. Sudden onset
Initiation of the tachycardia may also provide information on the mechanism and origin of
the arrhythmia. The heart rate in the case of a sinus tachycardia at physical activity rises
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slowly and gradually. Other SVTs or ventricular arrhythmias cause a sudden and marked
jump in the heart rate (or fall in CL). Primary role of the Sudden onset criterion is therefore
the diagnose of sinus tachycardia (figures 10 and 11). However, in some studies the algo‐
rithm using this criterion resulted in delayed VT detection (figure 12) or could not show sig‐
nificant reduction of inappropriate ICD therapy (table 5). Therefore, programming of
sudden onset criterion is recommended above all in younger patients who could reach high
HR at physical activity and could tolerate longer the hemodynamic consequences of a po‐
tential VT. This group is generally underrepresented in large ICD studies, which may be the
reason why the effect on the incidence of inappropriate ICD therapy could not be proven.
Figure 10. Demonstration of sudden onset calculation: The device compares RR1 with mean from RR2 to RR5 (Biotro‐
nik), onset (%) = (RR1*100]/mean from RR2 to RR5 for Boston, standard 10% or for Medtronic graduated onset (%)
mean from RR1 to RR4 / mean RR5 to RR8, standard 81%
Figure 11. Demonstration of the St. Jude Medical algorithm for sudden onset (standard ∆150-160]. In this case of ∆
<200ms the algorithm decides for SVT.
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Programming Inappropriate shock No inappropriate shock P value
Single chamber
Number of patients 83 83
Lowest VT zone (beats/min) 169.3 ± 19.9 171.9 ± 14.5 0.540
Lowest VT zone detection time (s) 2.45 ± 1.99 2.42 ± 2.07 0.830
Stability on % (n) 17 (14) 36 (30) 0.030
Sudden onset on % (n) 16 (13 23 (19) 0.160
Dual chamber
Number of patients 32 36
V>a on% (n) 31 (10) 50 (18) 0.054
Atrial fibrillation discriminator on % (n) 34 (11) 44 (16) 0.210
Table 5. Influences of discrimination algorithms to inappropriate ICD-shock according to single and dual chamber
detection in MADIT II trial [4].
Figure 12. Notice prolonged detection of sustained VT caused by graduated onset algorithm of a Medtronic device.
There is a VT with obviously change in vector and stable CL of 370 ms. The graduated onset is calculated graduated
caused by 10 beats of another tachycardia leads to a negative sudden onset criteria.
9. Timer
Depending from manufacturers a time window can be defined for SVT/VT discrimination in
VT zones. In case of an episode identified as SVT the device may suspend the programmed
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therapy only within this specified time interval, when the time runs out, the device delivers
VT therapy (SVT time out). Also in case of an episode identified as VT the device may
switch to the VF therapy after a specified time interval (VT time out). Generally these coun‐
ters are not recommended because SVTs usually continue for longer time periods and such
timer could force an ATP or shock delivery inappropriately. However, in individual cases
(e.g. in patients with very low ejection fraction who could not tolerate higher HR for a lon‐
ger time) programming a time out intervals may be considered for safety reasons.
10. Morphology criteria
Morphology and width of QRS complexes is a primary tool for physicians to differentiate
SVT from VT (table 3 and 4). Accordingly, almost all manufacturers have developed QRS
complex morphology algorithms. The device compare 8 or more voltage points on the EGM
signals at different time points (figure 13). A point to point assessment of each complex to a
defined standard complex (template) follows. Finally, decision is made based on a previous‐
ly programmed matching-ratio in percentage (figure 14). Currently, programming of this
criterion is recommended in single chamber devices and in dual chamber devices in case of
V<A and V=A. The algorithms use either EGM only or a combination of EGM and a can to
coil lead (figure 15). In case of no intrinsic activation like third degree atrioventricular block
or continuous biventricular pacing the automatic storing algorithm of QRS complex tem‐
plate may be problematic or even not possible. In the latter case QRS template should be
stored manually during pacing inhibition. In case of HR dependent bundle branch block this
algorithm may also fail to differentiate tachycardias.
Figure 13. Demonstration of morphology score calculation: match or not match based on percentage template
match threshold measurement by St. Jude Medical window detection algorithm. In this case of 6 matches from 8 the
algorithm votes for SVT [75%).
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Figure 14. Demonstration of sensitivity and specify of the Medtronic Wavelet™ algorithm to differentiate between
SVT and VT by Klein et al [24]. As recommendation a value of 70% match is standard by Medtronic devices.
Figure 15. Demonstration of the Rhythm ID™ discrimination algorithm: discrimination between sinus rhythm and SVT
with “normal” vector (green) to a potential VT vector (red). This algorithm is not based on EGM signal but on an inter‐
nal ECG electrode from device can to RV shock coil and the vena cava shock coil.
11. SVT/VT discrimination algorithms in single chamber devices
In the programming of single chamber ICD the three most important discrimination criteria
are stability, morphology and sudden onset. However, it should be defined whether a single
criterion or only matching of all three criteria should rule out a VT. Currently, if all three
criteria are active, it is recommended to rule out VT in case of 2 out of 3 votes for SVT. If
Tachycardia Discrimination Algorithms in ICDs
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only two criteria are active (standard), stability and morphology are recommended, and 1
out 2 votes is required for the diagnosis of SVT. Anyway, differentiation between SVT and
VT in single as well as dual chamber ICD remains difficult and should be carefully checked
by the physician at each follow-up visit (figure 16a-b).
 
(a) 
(b) 
Figure 16. a: This episode of a dual chamber tachycardia detection (Atlas DR St. Jude Medical) with A>V during AF
with a CL around 100ms demonstrates the hardly difficult decision-making in spite of all common discrimination algo‐
rithms. The ventricular EGM shows a fast stable tachycardia with a CL of around 300ms and sudden onset as well as
nearly same EGM signal like intrinsic activation before. This tachycardia falls in VF zone and the morphology criteria
founds a match to intrinsic activation of stored template. Although morphology votes for SVT, stability outvote for VT
<40ms (sudden onset not active), but anyway the CL falls in VF zone in this case without active SVT discrimination
algorithm the device detected this episode as VF and start charging shock therapy (*). b: The same episode stopped
spontaneously without any therapy and the shock is aborted by the device. The example underlined the importance
of long detection intervals (TDI 18-24 not 12 like in this case), the need of competent discrimination algorithm also in
short CL under 300ms and the difficult interpretation of an episode not only by the device but also by physicians in
decision making SVT or VT.
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12. SVT/VT discrimination algorithms in dual chamber devices
Detection and diagnose of arrhythmias in dual chamber devices is more complex, and the
mechanism of decision making is harder to demonstrate. Discrimination algorithms are still
based on the principles explained above. Significant addition is the comparison of atrial (A)
and ventricular (V) frequency (figure 17). In case of V>A VT therapy is initiated directly. For
cases with V=A or V<A further discrimination algorithms are used to differentiate between
SVT and VT. For V<A programming of morphology and stability criteria is recommended. For
V=A programming of morphology criterion may be sufficient. In addition for V<A episodes
measurement of the A-V-A intervals may differentiate SVTs with 2:1 activation from VTs with
VA dissociation during AF/Aflut. Measurement of A-V-A intervals by St. Jude Medical devi‐
ces (AV Detection Enhance™) is illustrated in figure 18a-b. This algorithm counts the last 12
AV intervals and calculates the difference between the second longest and second shortest AV
interval; difference < 40ms suggests association between A and V and decides for SVT. A com‐
parable algorithm based on pattern recognition typical for Aflut or SVT with 1:1 AV-conduc‐
tion is used by Medtronic called PR-Logic™ and by Biotronik called SMART™. Sorin use an
algorithm more orientated to CL stability called PARAD(+)™[9].
Figure 17. The rate branch differentiates between V<A, V=A and V>A. For VA dissociation a VT will therapies by ICD
directly. In case of V=A a sinus tachycardia or other 1:1 SVT should inhibited by ICD and in case of retrograde activa‐
tion of a VT the ICD should delivered therapy. For V<A and AF/AFl therapy should inhibited and V<A with VT and cur‐
rent AF/AFl therapy should delivered.
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 (a) 
(b) 
Figure 18. a: This is an example for measurement AV association during AFl with 2:1 activation. Although stability says
stable CL <40ms there is an association between A and V. 160-150ms = 10ms for AVA interval (standard < 40ms for
SVT) indicate association with RA. The algorithm vote for SVT and AVA interval outvotes stability. b: This is an example
for measurement AV dissociation during AFl and VT. The second longest minus second shortest AV interval
(190ms-130ms=60ms) is voted by delta >40ms for dissociation and VT.
13. Tachy/Sinus ratio
Tachy/Sinus ratio counter is an algorithm from St. Jude Medical to avoid oversensing bige‐
miny during sinus tachycardia, t-wave oversensing or cluster caused by lead fracture. In fig‐
ure 19 calculation of CL ratio of 2.5 (500ms/200ms) over the last 12 sinus beats is illustrated.
For every ratio of 2.5 the algorithm counts -1, and for counter <3 over the last 12 beats the
algorithm votes for bigeminy and for >3 for VT. Medtronic has developed an algorithm
called Lead Integrity Alert™; a short RR counter combined with daily lead impedance mon‐
itoring as early warning system for lead fracture. These algorithms have growing impor‐
tance due to the rising number of lead fracture problems over the last years. Biotronik also
developed its t-wave detection protection algorithm. Furthermore, all manufacturers use an
automatic gain control as dynamic sense control to avoid t-wave oversensing.
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Figure 19. This is an example for measurement Tachy/Sinus ratio. Over the last 12 interval the ratio 500/200 turns out
2.5. For this value the algorithm counts -1 and calculate this over the last 12 beats. For a value <3 SVT and >3 VT is
assumed.
14. Decision making for single or dual chamber ICD
In the last decade the issue of implanting single or dual chamber ICD was thoroughly dis‐
cussed. The negative influence of ventricular pacing in DAVID I trial [10] could be avoided
in the DAVID II trial [11], which demonstrated similar prognoses in single and dual cham‐
ber patients for freedom of unfavourable ventricular pacing. The 1&1 trail of Bansch et al [9]
failed (p=0.08) to demonstrate superiority of dual chamber devices to prevent inappropriate
therapy in ICD patients. Also in MADIT II no benefit for dual chamber ICD patients could
be confirmed [4]. The Detect SVT study by Friedman et al [12] could show a significant de‐
crease of inappropriate therapy in dual chamber patients (with 30.9% in 1,090 episodes ver‐
sus 39.5% in 1,253 episodes in single chamber ICD patients (p=0,03, see figure 20).
Superiority was reported in the diagnose of AF, Aflut and atrial tachycardia (figure 21). No
benefit could be demonstrated in sinus tachycardia, lead dysfunction and t-wave oversens‐
ing. Still, even dual chamber ICDs may fail to discriminate appropriately (figure 22a-f). This
figure also may help to explain why inappropriate ICD therapy could have a negative effect
on mortality in ICD patients. An recently, not jet published abstract of HRS congress 2012 of
Friedman et al. of a prospective randomized trail of dual chamber versus single chamber
ICD to minimize shocks in optimally programmed devices with optimal 30/40 detection of
Medtronic devices no significant superiority of dual chamber devices could measure in at‐
tention to inappropriate therapies. Significant more AF was detected in the dual chamber
device group. Generally, the choice of single or dual chamber does not depend on the inten‐
tion of a better SVT discrimination (e.g. patients with paroxysmal AF). Main indication for
dual chamber ICD is the necessity of atrial pacing.
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Figure 20. Comparison of inappropriate SVT detection in single and dual chamber ICDs. Notice 30.9% inappropriate
SVT detection in 1,090 episodes in dual chamber versus 39.5% in 1,253 episodes in single chamber ICD patients
(p=0.03) [12].
Figure 21. Comparison of inappropriate SVT detection in single and dual chamber ICDs. A trend for superiority was
estimated in AF, AFl and atrial tachycardia in the Detect SVT study [12].
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Tachycardia Discrimination Algorithms in ICDs
http://dx.doi.org/10.5772/52657
155
 (d) 
(e) 
(f) 
Figure 22. a: Demonstration of an AF episode in a CRT-D device with dual chamber detection (Promote St. Jude Medi‐
cal) A>V with CL around 344 to 270ms. Depending of CL the device counts VT (T) and VF (F) beats for detection. In this
device no SVT discrimination algorithms are allowed in VF zone. b: Same episode 12 seconds later. After detection VT
episode (NID 12] first VT therapy (ATP) is given. c: Same episode 27 seconds later. After acceleration of AF a VF episode
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is detected (NID 12] and the first shock is delivered. d: Same episode 43 seconds later. After the first shock ventricular
fibrillation with syncope of patient is following, second shock (ineffective) at second 52 of episode is delivered. e:
Same episode 65 seconds later. The third shock, now effective, is delivered during ventricular fibrillation and episode
ends with sinus rhythm.f: This picture of the same episode turns out reasons for detection of AF in the VT zone. A
temporary AF undersensing in RA rolls this episode in V=A branch. Generally based from 1:1 tachycardia in this branch
stability is not sensible and programmed in this branch. In this case there are morphology and sudden onset discrimi‐
nation active. For understandable reasons morphology votes for SVT and sudden onset for VT and resulting VT thera‐
py starts. As previously described sudden onset criteria is not recommended in this branch and an always problematic
discrimination algorithm.
15. Summary/Conclusion
Avoiding of inappropriate therapy delivery is one of the major issues in ICD therapy. In the
last decade several new algorithms were developed to improve sensitivity and specificity of
tachycardia detection. Current recommendation for primary prevention patients is the pro‐
gramming of a fast VT zone from 187 to 250 bpm with long NID or DT [30/40] for Medtron‐
ic, 12 seconds for Boston, 18/24 for St. Jude Medical and Biotronik), is ATP prior or during
charging followed by shock therapy. For devices that not allow SVT discrimination in this
zone a separate VF zone above 250 bpm should be programmed to make SVT discrimination
possible in a VT zone of 187 to 250 bpm. If a second VT zone around 150-187 bpm is pro‐
grammed, a long NID (minimum 25 beats or 60 seconds) with stability and morphology dis‐
crimination algorithm without time out rule is recommended. Algorithms for early
detection of lead fracture, sinus/tachy ratio and impedance monitoring are recommended
when available. In patients with long QT syndrome or other risk for primary VF a single
zone over 220 bpm is recommended. In dual chamber ICDs stability, morphology and A-V-
A (or equivalent) SVT discrimination algorithms are recommended in the analysis of V=A
and V<A tachycardias. Implantation of dual chamber ICD for better SVT/VT discrimination
only is not indicated by currently available studies.
No algorithm is sensitive or specific enough to substitute the individual adaptation of ICD
detection and therapy for every patient. Detailed knowledge of ICD algorithms may provide
the necessary basis for the cardiologist to program devices individualized for each patient.
Stored episodes should be carefully evaluated at every follow-up visit to further improve
discrimination of SVTs and VTs.
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